Pfizer Inc. (PFE)
NYSE · Healthcare
Pfizer Inc. Shareholder Equity 2007–2025
Pfizer Inc. annual shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Pfizer Inc. shareholder equity as of December 31, 2025: 86.48B, a 1.96% decrease year-over-year.
- Pfizer Inc. shareholder equity for 2025 were 86.48B, a 1.96% decrease from 2024.
- Pfizer Inc. shareholder equity for 2024 were 88.20B, a 0.91% decrease from 2023.
- Pfizer Inc. shareholder equity for 2023 were 89.01B, a 6.95% decrease from 2022.
- Pfizer Inc. shareholder equity for 2022 were 95.66B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Pfizer Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $86,476 |
| 2024 | $88,203 |
| 2023 | $89,014 |
| 2022 | $95,661 |
| 2021 | $77,201 |
| 2020 | $63,238 |
| 2019 | $63,143 |
| 2018 | $63,407 |
| 2017 | $71,308 |
| 2016 | $59,544 |
| 2013 | $76,307 |
| 2012 | $81,260 |
| 2011 | $82,190 |
| 2010 | $87,813 |
| 2009 | $90,014 |
Pfizer Inc. Shareholder Equity — FAQ
Pfizer Inc. (PFE) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PFE's shareholder equity history?
The chart and table above show Pfizer Inc.'s shareholder equity by year and by quarter, including the growth rate.